{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/28/3352471/0/en/hutchmed-announces-nmpa-approval-for-atled-fanregratinib-for-the-treatment-of-patients-with-fgfr2-fusion-rearrangement-intrahepatic-cholangiocarcinoma.html", "message": "News view counter 906572 successfully enlarged"}